α2β1 Integrin Ligand Peptide

Cat. No. M53341

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

α2β1 Integrin Ligand Peptide interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells.

Molecular Weight	390.35
Formula	C14H22N4O9
CAS Number	134580-64-6
Solubility (25°C)	Water
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Integrin Products
Volociximab Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs).
GSK 3008348 hydrochloride GSK 3008348 hydrochloride is a small molecule integrin αvβ6 antagonist.
HSDVHK-NH2 HSDVHK-NH2 is an antagonist of the integrin αvβ3-vitronectin interaction, with an IC50 of 1.74 pg/mL (2.414 pM).
LDV LDV, a tripeptide, is a non-fluorescent analog of LDV-FITC.
Cyclo(RADfK) Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.

Catalog